Company & Sponsor Intelligence
University Hospital, Tours
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials1
Recruiting0
Completed0
Countries1
Therapeutic footprint
unclassified
Indexed studies
NCT03436017Identification of Biomarkers of Attention Deficit Disorder With or Without Hyperactivity (ADHD) by a Metabolomic Approach in Children
adhd · FranceCOMPLETED
adhd · FranceCOMPLETED
NCT00245778fMRI Study of Grasping in Autistic Patients
autism · FranceTERMINATED
autism · FranceTERMINATED
NCT02719951Glutaminergic Transmission in Autism : Molecular Imaging Exploration
autism · FrancePHASE1
autism · FrancePHASE1
NCT02393027Quantification of Dopamine Active Transporter (DAT) in Humans: Validation of a New Radiophamaceutical, the [18F] LBT-999
unclassified · FranceEARLY_PHASE1
unclassified · FranceEARLY_PHASE1
Intelligence layer updated: 2026-06-10 02:57:56.223123+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →